Latest news with #LANXESS
Yahoo
2 days ago
- Business
- Yahoo
MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the PFAS Testing Quadrant Report 2025
DELRAY BEACH, Fla., June 6, 2025 /PRNewswire/ -- 360Quadrants has released its latest PFAS testing Startups/SMEs Companies Assessment, 2025, recognizing key players, including both global giants and emerging innovators, for their excellence in market presence, product innovation, and business strategy. The report highlights Restek Corporation, LANXESS, Evonik, and Cytiva among the top companies that are actively shaping the future of the PFAS testing Startups/SMEs Companies Assessment. The evaluation leverages 360Quadrants' proprietary methodology to map competitive positioning across 7,000+ micro markets within 10+ industries, enabling decision-makers to make strategic, data-backed vendor choices. Company Highlights in the PFAS testing Startups/SMEs Companies Assessment: Restek Corporation is a privately held company specializing in the development and manufacturing of high-performance chromatography columns and accessories. Renowned for its innovation and precision, Restek offers a broad portfolio of analytical solutions tailored for the analysis and quality monitoring of air, water, soil, food, pharmaceuticals, chemicals, and petroleum products. In addition to its chromatography products, Restek provides a comprehensive range of certified reference standards that support critical applications in environmental testing, clinical diagnostics, forensic science, toxicology, petrochemical analysis, and pharmaceutical research. Serving laboratories and research institutions around the globe, Restek is widely recognized for delivering reliable, high-quality products that meet the evolving needs of analytical science professionals. Evonik Industries AG, based in Essen, Germany, is a leading global specialty chemicals company known for delivering high-performance materials and innovative solutions across a broad range of industries, including healthcare, nutrition, coatings, agriculture, and energy. With a strong emphasis on sustainability and resource efficiency, Evonik leverages advanced research and development to drive innovation and support environmentally responsible practices. Evonik is actively pursuing the development of sustainable, fluorine-free alternatives. This includes the creation of advanced surfactants, coatings, and additives designed to replace traditional PFAS-based materials, reinforcing the company's commitment to safer, more sustainable chemical solutions. LANXESS is a specialty chemicals company headquartered in Cologne, Germany, established in 2004 as a spin-off from Bayer AG's chemicals division and select polymer operations. With a global presence spanning 32 countries, LANXESS focuses on the development, production, and marketing of high-quality chemical intermediates, additives, and consumer protection products. To explore the full quadrant report and see how companies are positioned in the PFAS testing Startups/SMEs Companies Assessment, 2025, Visit: Evaluation Criteria The vendor evaluation was conducted on over 130 companies, of which the top 10 were categorized and recognized as quadrant leaders. Factors such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the PFAS Testing Startups/Small-Medium Businesses Companies Assessment quadrant. The top criteria for product footprint evaluation included Product (Instruments, consumables, and software & services), Technique (Liquid chromatography with tandem mass spectrometry (LC-MS/MS), gas chromatography-mass spectrometry (GC-MS), NMR spectroscopy, mass spectrometry, combustion ion chromatography, enzyme-linked immunosorbent assays (ELISA), and other techniques), and Methods (EPA, DIN, ISO, ASTM, and Other methods), and Application. 360 Quadrants Scoring Methodology 360 Quadrants employs a comprehensive and transparent scoring methodology to evaluate companies. It identifies relevant evaluation criteria, collects and validates data from multiple sources, and employs an algorithm that considers parameter weights to generate scores. Normalization ensures fair comparisons, and the aggregated scores categorize solutions into quadrants such as Progressive companies, Responsive companies, Dynamic companies, and Starting blocks. This unbiased approach equips users with accurate information, empowering them to make well-informed decisions and select solutions that best suit their needs and objectives. Download Free Sample @ About 360Quadrants 360Quadrants, a specialized division of MarketsandMarkets™, delivers comprehensive quadrant analyses for various emerging technologies and markets, including start-ups. Our evaluation methodology hinges on two critical parameters: market presence and product footprint. This approach facilitates a graphical representation of competitive positioning across four key categories: leaders, contenders, innovators, and emerging companies. In addition, we meticulously classify start-ups into progressive companies, responsive companies, dynamic companies, and starting blocks. Our expertise equips organizations with insights into market leaders across over 6000 micro markets, enabling a detailed comparison of vendor capabilities and performance. At 360Quadrants, we ensure that each quadrant adheres to the highest standards, empowering our clients to navigate complex market dynamics precisely and confidently. 360Quadrants has also launched quadrants in fields such as - Material Informatics Startups/SMEs Companies Assessment, 2025, and Livestock Monitoring Startups/SMEs Companies Assessment, 2025. About MarketsandMarkets MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Ms. Sipti Banga,630 Dundee Road, Suite 430Northbrook, IL 60062USA: +1-888-600-6441Email: Logo: View original content: SOURCE MarketsandMarkets Sign in to access your portfolio
Yahoo
2 days ago
- Business
- Yahoo
MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the PFAS Testing Quadrant Report 2025
DELRAY BEACH, Fla., June 6, 2025 /PRNewswire/ -- 360Quadrants has released its latest PFAS testing Startups/SMEs Companies Assessment, 2025, recognizing key players, including both global giants and emerging innovators, for their excellence in market presence, product innovation, and business strategy. The report highlights Restek Corporation, LANXESS, Evonik, and Cytiva among the top companies that are actively shaping the future of the PFAS testing Startups/SMEs Companies Assessment. The evaluation leverages 360Quadrants' proprietary methodology to map competitive positioning across 7,000+ micro markets within 10+ industries, enabling decision-makers to make strategic, data-backed vendor choices. Company Highlights in the PFAS testing Startups/SMEs Companies Assessment: Restek Corporation is a privately held company specializing in the development and manufacturing of high-performance chromatography columns and accessories. Renowned for its innovation and precision, Restek offers a broad portfolio of analytical solutions tailored for the analysis and quality monitoring of air, water, soil, food, pharmaceuticals, chemicals, and petroleum products. In addition to its chromatography products, Restek provides a comprehensive range of certified reference standards that support critical applications in environmental testing, clinical diagnostics, forensic science, toxicology, petrochemical analysis, and pharmaceutical research. Serving laboratories and research institutions around the globe, Restek is widely recognized for delivering reliable, high-quality products that meet the evolving needs of analytical science professionals. Evonik Industries AG, based in Essen, Germany, is a leading global specialty chemicals company known for delivering high-performance materials and innovative solutions across a broad range of industries, including healthcare, nutrition, coatings, agriculture, and energy. With a strong emphasis on sustainability and resource efficiency, Evonik leverages advanced research and development to drive innovation and support environmentally responsible practices. Evonik is actively pursuing the development of sustainable, fluorine-free alternatives. This includes the creation of advanced surfactants, coatings, and additives designed to replace traditional PFAS-based materials, reinforcing the company's commitment to safer, more sustainable chemical solutions. LANXESS is a specialty chemicals company headquartered in Cologne, Germany, established in 2004 as a spin-off from Bayer AG's chemicals division and select polymer operations. With a global presence spanning 32 countries, LANXESS focuses on the development, production, and marketing of high-quality chemical intermediates, additives, and consumer protection products. To explore the full quadrant report and see how companies are positioned in the PFAS testing Startups/SMEs Companies Assessment, 2025, Visit: Evaluation Criteria The vendor evaluation was conducted on over 130 companies, of which the top 10 were categorized and recognized as quadrant leaders. Factors such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the PFAS Testing Startups/Small-Medium Businesses Companies Assessment quadrant. The top criteria for product footprint evaluation included Product (Instruments, consumables, and software & services), Technique (Liquid chromatography with tandem mass spectrometry (LC-MS/MS), gas chromatography-mass spectrometry (GC-MS), NMR spectroscopy, mass spectrometry, combustion ion chromatography, enzyme-linked immunosorbent assays (ELISA), and other techniques), and Methods (EPA, DIN, ISO, ASTM, and Other methods), and Application. 360 Quadrants Scoring Methodology 360 Quadrants employs a comprehensive and transparent scoring methodology to evaluate companies. It identifies relevant evaluation criteria, collects and validates data from multiple sources, and employs an algorithm that considers parameter weights to generate scores. Normalization ensures fair comparisons, and the aggregated scores categorize solutions into quadrants such as Progressive companies, Responsive companies, Dynamic companies, and Starting blocks. This unbiased approach equips users with accurate information, empowering them to make well-informed decisions and select solutions that best suit their needs and objectives. Download Free Sample @ About 360Quadrants 360Quadrants, a specialized division of MarketsandMarkets™, delivers comprehensive quadrant analyses for various emerging technologies and markets, including start-ups. Our evaluation methodology hinges on two critical parameters: market presence and product footprint. This approach facilitates a graphical representation of competitive positioning across four key categories: leaders, contenders, innovators, and emerging companies. In addition, we meticulously classify start-ups into progressive companies, responsive companies, dynamic companies, and starting blocks. Our expertise equips organizations with insights into market leaders across over 6000 micro markets, enabling a detailed comparison of vendor capabilities and performance. At 360Quadrants, we ensure that each quadrant adheres to the highest standards, empowering our clients to navigate complex market dynamics precisely and confidently. 360Quadrants has also launched quadrants in fields such as - Material Informatics Startups/SMEs Companies Assessment, 2025, and Livestock Monitoring Startups/SMEs Companies Assessment, 2025. About MarketsandMarkets MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Ms. Sipti Banga,630 Dundee Road, Suite 430Northbrook, IL 60062USA: +1-888-600-6441Email: Logo: View original content: SOURCE MarketsandMarkets
Fashion Value Chain
02-05-2025
- Business
- Fashion Value Chain
LANXESS India Hosts First Solutions Day in Mumbai
LANXESS India, a leader in specialty chemicals, successfully hosted its inaugural Solutions Day in Mumbai, bringing together customers and industry partners to explore its diverse and sustainability-driven product portfolio. All nine of the company's business units were represented: Advanced Industrial Intermediates, Flavors & Fragrances, Inorganic Pigments, Liquid Purification Technologies, Lubricant Additives Business, Material Protection Products, Polymer Additives, Rhein Chemie, and Saltigo. The event, themed around 'One LANXESS,' emphasized the company's integrated, cross-business approach, showcasing solutions across multiple industrial segments. It underlined LANXESS' strategic transition from a polymer-focused enterprise to a specialty chemicals innovator, now organized around three key pillars: Consumer Protection Products, Specialty Additives, and Advanced Industrial Intermediates. Solutions Day featured interactive sessions, technical showcases, and networking, aimed at sparking collaboration and knowledge sharing among business units and with stakeholders. Namitesh Roy Choudhury, Vice Chairman & MD of LANXESS India, emphasized the company's commitment to sustainable growth and responsible innovation, stating that the event fosters deeper partnerships and demonstrates how LANXESS' solutions can address global industrial challenges.
Yahoo
29-03-2025
- Business
- Yahoo
Standard Lithium Corp (SLI) Q2 2025 Earnings Call Highlights: Strategic Partnerships and ...
Net Loss: $24.7 million for the three months ended December 31, 2024. Impairment Expense: $19.7 million due to the reduction of the carrying value of California properties to zero. General and Administrative Expenses: Reduced to approximately $2.7 million from $6.8 million quarter-over-quarter. Demonstration Plant Expenses: Decreased from approximately $2 million to $0.8 million. Management and Director Fees: Reduced from $1 million to $0.4 million. Working Capital: Approximately $27.5 million as of December 31, 2024. Cash Balance: Approximately $31.2 million at the end of 2024. Equinor Sole Funding: Development plans at East Texas and Southwest Arkansas are being sole funded up to $20 million and $40 million, respectively. Release Date: March 28, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Standard Lithium Corp (SLI) has formed a strategic partnership with Equinor, which validates the quality of their team and resources. The company successfully closed a $225 million grant from the DOE, indicating strong governmental support for their Southwest Arkansas project. Lithium recovery at the Southwest Arkansas project exceeded design criteria, recovering over 99% of lithium from brine. The company has made significant progress in securing leases in East Texas, with plans to publish a maiden inferred resource report. Operational cost reductions have been achieved, with a near $6 million reduction in quarter-over-quarter burn rate. Standard Lithium Corp (SLI) reported a net loss of $24.7 million for the three months ended December 31, 2024, primarily due to an impairment of California assets. The company has reduced the carrying value of its California properties to zero, resulting in a $19.7 million impairment expense. Sole funding from Equinor for projects in East Texas and Southwest Arkansas is expected to run out next quarter, requiring Standard Lithium to start making capital contributions. There is continued uncertainty around pricing and demand in the lithium sector. The LANXESS project is not a current priority due to its relatively lesser grades and smaller scale compared to other projects. Q: What are your views on the recent executive order by the US administration to increase American mineral production, and how might it benefit Standard Lithium? A: David Park, CEO, stated that the executive order is viewed positively as it could facilitate and speed up regulatory approvals for projects like theirs and potentially open up additional funding sources. However, it's too early to provide specific details on the benefits. Q: When do you expect to finalize the royalty structure in Arkansas? A: David Park, CEO, mentioned that they have been actively engaged with the Arkansas government and stakeholders since last November and are confident of a positive outcome regarding the Arkansas royalty by the end of the second quarter of this year. Q: Can you discuss the status and future of the LANXESS project? A: David Park, CEO, explained that while the LANXESS project remains important, the focus is currently on developing higher-grade resources in Southwest Arkansas and East Texas with well-funded partners. Andy Robinson, COO, added that the team is focused on the Southwest Arkansas project for commercialization. Q: How wide is the net cast for potential off-take agreements, and is there a competitive race to secure customers? A: David Park, CEO, stated they started with about 40 potential counterparties, narrowing down to a few with whom they are in advanced discussions. He does not believe they are in a race with others to secure off-take, as there is robust demand for lithium carbonate in the 2028 and beyond timeframe. Q: How will the learnings from Southwest Arkansas be applied to East Texas projects? A: Andrew Robinson, COO, noted that they plan to leverage relationships with vendors and partners developed in Southwest Arkansas to streamline and reduce costs for East Texas projects, aiming for quicker and more efficient project development. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
31-01-2025
- Business
- Yahoo
Is LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 50% Discount?
Using the 2 Stage Free Cash Flow to Equity, LANXESS fair value estimate is €52.69 Current share price of €26.51 suggests LANXESS is potentially 50% undervalued The €28.50 analyst price target for LXS is 46% less than our estimate of fair value How far off is LANXESS Aktiengesellschaft (ETR:LXS) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. We will use the Discounted Cash Flow (DCF) model on this occasion. There's really not all that much to it, even though it might appear quite complex. We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model. Check out our latest analysis for LANXESS We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (€, Millions) €227.0m €266.3m €266.0m €309.0m €308.0m €308.2m €309.3m €310.9m €313.0m €315.3m Growth Rate Estimate Source Analyst x4 Analyst x4 Analyst x2 Analyst x1 Analyst x1 Est @ 0.08% Est @ 0.34% Est @ 0.53% Est @ 0.66% Est @ 0.75% Present Value (€, Millions) Discounted @ 7.2% €212 €232 €216 €234 €218 €203 €190 €178 €167 €157 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = €2.0b After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.0%. We discount the terminal cash flows to today's value at a cost of equity of 7.2%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = €315m× (1 + 1.0%) ÷ (7.2%– 1.0%) = €5.1b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= €5.1b÷ ( 1 + 7.2%)10= €2.5b The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is €4.5b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of €26.5, the company appears quite good value at a 50% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent. The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at LANXESS as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.2%, which is based on a levered beta of 1.516. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Strength No major strengths identified for LXS. Weakness Interest payments on debt are not well covered. Dividend is low compared to the top 25% of dividend payers in the Chemicals market. Opportunity Forecast to reduce losses next year. Has sufficient cash runway for more than 3 years based on current free cash flows. Trading below our estimate of fair value by more than 20%. Threat Debt is not well covered by operating cash flow. Whilst important, the DCF calculation shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. What is the reason for the share price sitting below the intrinsic value? For LANXESS, we've compiled three further factors you should assess: Risks: Take risks, for example - LANXESS has 1 warning sign we think you should be aware of. Future Earnings: How does LXS's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the XTRA every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
